Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Disease Progression and EZH2[original query] |
|---|
| EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood 2013 Oct 122 (18): 3165-8. Bödör Csaba, Grossmann Vera, Popov Nikolay, Okosun Jessica, O'Riain Ciarán, Tan King, Marzec Jacek, Araf Shamzah, Wang Jun, Lee Abigail M, Clear Andrew, Montoto Silvia, Matthews Janet, Iqbal Sameena, Rajnai Hajnalka, Rosenwald Andreas, Ott German, Campo Elias, Rimsza Lisa M, Smeland Erlend B, Chan Wing C, Braziel Rita M, Staudt Louis M, Wright George, Lister T Andrew, Elemento Olivier, Hills Robert, Gribben John G, Chelala Claude, Matolcsy András, Kohlmann Alexander, Haferlach Torsten, Gascoyne Randy D, Fitzgibbon Ju |
| Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 Dec 22 (12): 2333-44. Leinonen Katri A, Saramäki Outi R, Furusato Bungo, Kimura Takahiro, Takahashi Hiroyuki, Egawa Shin, Suzuki Hiroyoshi, Keiger Kerri, Ho Hahm Sung, Isaacs William B, Tolonen Teemu T, Stenman Ulf-Håkan, Tammela Teuvo L J, Nykter Matti, Bova G Steven, Visakorpi Tap |
| Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression. American journal of hematology 2014 Feb 89 (2): 181-6. Hou Hsin-An, Kuo Yuan-Yeh, Tang Jih-Luh, Chou Wen-Chien, Yao Ming, Lai Yan-Jun, Lin Chien-Chin, Chen Chien-Yuan, Liu Chieh-Yu, Tseng Mei-Hsuan, Huang Chi-Fei, Chiang Ying-Chieh, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Huang Shang-Yi, Ko Bor-Sheng, Wu Shang-Ju, Tsay Woei, Chen Yao-Chang, Tien Hwei-Fa |
| Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome. Blood cancer journal 2014 4 e177. Chen T-C, Hou H-A, Chou W-C, Tang J-L, Kuo Y-Y, Chen C-Y, Tseng M-H, Huang C-F, Lai Y-J, Chiang Y-C, Lee F-Y, Liu M-C, Liu C-W, Liu C-Y, Yao M, Huang S-Y, Ko B-S, Hsu S-C, Wu S-J, Tsay W, Chen Y-C, Tien H |
| Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease. Leukemia research 2017 Jun 60 18-23. Barosi Giovanni, Massa Margherita, Campanelli Rita, Fois Gabriela, Catarsi Paolo, Viarengo Gianluca, Villani Laura, Poletto Valentina, Bosoni Tiziana, Magrini Umberto, Gale Robert P, Rosti Vittor |
| Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid. The Journal of molecular diagnostics : JMD 2017 May . Mehrotra Meenakshi, Singh Rajesh R, Chen Wei, Huang Richard S P, Almohammedsalim Alaa A, Barkoh Bedia A, Simien Crystal M, Hernandez Marcos, Behrens Carmen, Patel Keyur P, Routbort Mark J, Broaddus Russell R, Medeiros L Jeffrey, Wistuba Ignacio I, Kopetz Scott, Luthra Rajyalaksh |
| Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 1 25 (6): 1142-1151. Tamari Roni, Rapaport Franck, Zhang Nan, McNamara Caroline, Kuykendall Andrew, Sallman David A, Komrokji Rami, Arruda Andrea, Najfeld Vesna, Sandy Lonette, Medina Juan, Litvin Rivka, Famulare Christopher A, Patel Minal A, Maloy Molly, Castro-Malaspina Hugo, Giralt Sergio A, Weinberg Rona S, Mascarenhas John O, Mesa Ruben, Rondelli Damiano, Dueck Amylou C, Levine Ross L, Gupta Vikas, Hoffman Ronald, Rampal Raajit |
| [Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 2004-2010. Cen Yan-Xia, Li Y |
| Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B-cell lymphoma. Cancer science 2021 1 112 (3): 1123-1131. Munakata Wataru, Shirasugi Yukari, Tobinai Kensei, Onizuka Makoto, Makita Shinichi, Suzuki Rikio, Maruyama Dai, Kawai Hidetsugu, Izutsu Koji, Nakanishi Tadashi, Shiba Sari, Hojo Seichiro, Ando Kiyos |
| The different variant allele frequencies of type I/type II mutations and the distinct molecular landscapes in CALR-mutant essential thrombocythaemia and primary myelofibrosis. Hematology (Amsterdam, Netherlands) 2022 8 27 (1): 902-908. Pan Yuxia, Wang Xingzhe, Wen Shupeng, Liu Xiaojun, Yang Lin, Luo Jianm |
| Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis. Cancers 2022 5 14 (10): . González-López Oscar, Muñoz-González Javier I, Orfao Alberto, Álvarez-Twose Iván, García-Montero Andrés |
| Determination of ERG(+), EZH2, NKX3.1, and SPINK-1 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer. Cancer reports (Hoboken, N.J.) 2022 10 e1728. Segura-Moreno Yenifer Yamile, Sanabria-Salas María Carolina, Mesa-López De Mesa Jorge Andrés, Varela-Ramirez Rodolfo, Acosta-Vega Natalia Lizeth, Serrano Martha Luc |
| Tazemetostat for Tumors Harboring SMARCB1/SMARCA4 or EZH2 Alterations: Results from NCI-COG Pediatric MATCH APEC1621C. Journal of the National Cancer Institute 2023 5 . Susan N Chi, Joanna S Yi, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton, Brent D Coffey, Joel M Reid, Jin Piao, Lauren Saguilig, Todd A Alonzo, Stacey L Berg, Nilsa C Ramirez, Alok Jaju, Joyce C Mhlanga, Elizabeth Fox, Douglas S Hawkins, Margaret M Mooney, Naoko Takebe, James V Tricoli, Katherine A Janeway, Nita L Seibel, D Williams Parso |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: